| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant Management of Pathologic Node–Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer
|
Polamraju, Praveen
|
|
2018
|
17 |
3 |
p. e519-e530
|
artikel
|
| 2 |
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study
|
Pastorino, Alessandro
|
|
2018
|
17 |
3 |
p. e457-e470
|
artikel
|
| 3 |
A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer
|
Liang, Lijun
|
|
2018
|
17 |
3 |
p. e443-e449
|
artikel
|
| 4 |
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial
|
Jonker, Derek J.
|
|
2018
|
17 |
3 |
p. 231-239.e7
|
artikel
|
| 5 |
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study
|
McSkane, Michelle
|
|
2018
|
17 |
3 |
p. 215-222.e3
|
artikel
|
| 6 |
Cancer Stemness, Immune Cells, and Epithelial–Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma
|
Xu, Fangying
|
|
2018
|
17 |
3 |
p. e579-e592
|
artikel
|
| 7 |
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
|
Lee, Su Jin
|
|
2018
|
17 |
3 |
p. 165-169
|
artikel
|
| 8 |
Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer
|
Venigalla, Sriram
|
|
2018
|
17 |
3 |
p. e557-e568
|
artikel
|
| 9 |
Corrigendum
|
|
|
2018
|
17 |
3 |
p. 247
|
artikel
|
| 10 |
Editorial Board
|
|
|
2018
|
17 |
3 |
p. A1
|
artikel
|
| 11 |
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
|
Baretti, Marina
|
|
2018
|
17 |
3 |
p. e489-e498
|
artikel
|
| 12 |
Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients With Rectal Cancer During the First 2 Years After Diagnosis
|
Couwenberg, Alice M.
|
|
2018
|
17 |
3 |
p. e499-e512
|
artikel
|
| 13 |
Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies
|
Boeckx, Nele
|
|
2018
|
17 |
3 |
p. 170-178.e3
|
artikel
|
| 14 |
Efficacy and Tolerability of Second-line Nab-paclitaxel and Gemcitabine After Failure of First-line FOLFIRINOX for Advanced Pancreas Cancer: A Single-institution Experience
|
Zhang, Hanbo
|
|
2018
|
17 |
3 |
p. e451-e456
|
artikel
|
| 15 |
Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer
|
Kim, Tae Won
|
|
2018
|
17 |
3 |
p. 206-214
|
artikel
|
| 16 |
Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber
|
Chen, Jiezhong
|
|
2018
|
17 |
3 |
p. e541-e544
|
artikel
|
| 17 |
Meta-analysis of Modified FOLFIRINOX Regimens for Patients With Metastatic Pancreatic Cancer
|
Usón Junior, Pedro Luiz Serrano
|
|
2018
|
17 |
3 |
p. 187-197
|
artikel
|
| 18 |
Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer
|
Kawai, Kazushige
|
|
2018
|
17 |
3 |
p. 240-246
|
artikel
|
| 19 |
Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection
|
Kim, Chan
|
|
2018
|
17 |
3 |
p. e513-e518
|
artikel
|
| 20 |
Previous Bevacizumab and Efficacy of Later Anti–Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry
|
Burge, Matthew
|
|
2018
|
17 |
3 |
p. e593-e599
|
artikel
|
| 21 |
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer
|
Sawada, Kentaro
|
|
2018
|
17 |
3 |
p. 198-205
|
artikel
|
| 22 |
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study
|
Hanna, Diana L.
|
|
2018
|
17 |
3 |
p. e471-e488
|
artikel
|
| 23 |
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study
|
Schirripa, Marta
|
|
2018
|
17 |
3 |
p. e601-e615
|
artikel
|
| 24 |
Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib
|
Patel, Anuj K.
|
|
2018
|
17 |
3 |
p. e531-e539
|
artikel
|
| 25 |
Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer
|
Brungs, Daniel
|
|
2018
|
17 |
3 |
p. e549-e555
|
artikel
|
| 26 |
Small Intestine Neuroendocrine Tumor in a Patient With MUTYH Adenomatous Polyposis—Case Report and SEER Analysis
|
Weidner, Tiffany K.
|
|
2018
|
17 |
3 |
p. e545-e548
|
artikel
|
| 27 |
Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival
|
Lee, Margaret M.
|
|
2018
|
17 |
3 |
p. e569-e577
|
artikel
|
| 28 |
Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients
|
Davidson, Michael
|
|
2018
|
17 |
3 |
p. 223-230
|
artikel
|
| 29 |
Table of Contents
|
|
|
2018
|
17 |
3 |
p. A3-A8
|
artikel
|
| 30 |
Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer
|
Jacobs, Lotte
|
|
2018
|
17 |
3 |
p. 179-186
|
artikel
|
Tijdschrift beschrijving